Elevated hemoglobin and hematocrit are associated with the risk of coronary heart disease

Objective: Hemoglobin and hematocrit tests are routinely performed. However, they are often ignored for evaluation of coronary heart disease (CHD) patients. The aim of this study is to compare hemoglobin and hematocrit levels between CHD patients and healthy individuals. Materials and Methods: During January to June 2016, a retrospective was conducted in Aisyiyah Hospital, Malang, Indonesia. The following information was extracted from medical record, i.e.: gender, age, diagnosis, level of hematocrit, and hemoglobin. We analyzed the data using multiple logistic regression test. Results: We compared level of hematocrit and hemoglobin of 133 CHD patients and 50 controls. Our results showed that elevated hemoglobin [odds ratio (OR) 95% confidence interval (CI)=20.80 (2.65-163.02), p=0.004] and hematocrit [OR 95% CI=2.17 (1.11-4.25), p=0.024] were associated with the risk of CHD. Conclusion: Hemoglobin and hematocrit are associated with the risk of CHD.